DOCSLIB.ORG

Author Guidelines Information About FEBS Open Bio

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Author Guidelines Information About FEBS Open Bio Author Guidelines Information about FEBS Open Bio .......................................................................................................... 1 Editorial Policies ............................................................................................................................................. 2 Types of manuscripts .................................................................................................................................... 4 Preparing your manuscript ....................................................................................................................... 5 After Acceptance .......................................................................................................................................... 12 Frequently asked questions ..................................................................................................................... 13 Information about FEBS Open Bio Aims and Scope FEBS Open Bio is an online-only open access journal for the rapid publication of research articles in molecular and cellular life sciences in both health and disease. The journal's peer review process focuses on the technical soundness of papers, leaving the assessment of their impact and importance to the scientific community. FEBS Open Bio publishes experimental findings, critical analysis, methodological and technical innovations, and hypotheses. Novel or innovative work is encouraged, but papers describing sound science of a confirmatory nature in developing fields or extending knowledge of an important topic from one organism to another will also be considered. Articles originally submitted to other FEBS Press publications (FEBS Letters , The FEBS Journal and Molecular Oncology) can be transferred for consideration by FEBS Open Bio with their original reviewer reports, without the need to resubmit or reformat the manuscript. Why publish in FEBS Open Bio? FEBS Open Bio offers: • Easy online manuscript submission and tracking system • Fast and helpful peer review - median time to first decision 28 days in 2016 • Transfer service for articles from other FEBS journals, conserving peer reviews • Fast publication • Accepted articles published online within 7 days • Author-corrected final version available within 20 days • All articles are deposited in PubMed Central and indexed in PubMed Editorial board Information about the journal’s editorial board is available here: https://febs.onlinelibrary.wiley.com/hub/journal/22115463/editorial-board/editorial-board Contact us For inquiries relating to the submission or reviewing process, please contact the Editorial Office at [email protected]. Contact details for questions arising after acceptance of an article, especially those relating to proofs, will be provided by our publishers, Wiley. November 2018 1 Open access license and article processing charge Open access license This journal is Open Access; all articles will be immediately and permanently free for everyone to read and download. If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper. FEBS Open Bio offers corresponding authors the following license agreement: Creative Commons Attribution License CC BY To preview the terms and conditions of this open access agreement, please visit http://creativecommons.org/licenses/by/4.0/. Article processing charge FEBS Open Bio is an Open Access journal with no subscribers. A fee is payable by the author or research funder to cover the costs associated with publication. This ensures each article will be immediately and permanently free for anyone to access. The Open Access publication fee for this journal is $1495, excluding taxes. Authors will be asked to pay the article publication charge on acceptance of their article. For articles for the Education Section, the publication costs will be covered by FEBS. Your institute or funder may have an agreement with Wiley to pay all or some of the article publication charge on your behalf. You can check here. Waivers and discounts are available to authors from countries eligible for the Research4Life programs. You can check the lists of countries here. Questions related to Open Access publication fees and waivers should be sent to [email protected] Education Section The Education section of FEBS Open Bio is devoted to research articles in molecular and cellular life sciences education, with the aim of disseminating advice on education techniques and resources. Articles dealing with best practice, innovative methods, teaching bioinformatics, and use of technology in education are welcome, as are those more specifically aimed at internationalization, training or career planning. There is no cost to authors for this section as the publication costs will be covered by FEBS. Editorial Policies Ethical standards All submissions to FEBS Open Bio should conform to standard ethical guidelines, details of which can be found on the website of the Committee on Publication Ethics (COPE). See also Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals http://www.icmje.org November 2018 2 FEBS Open Bio employs a plagiarism detection system (iThenticate). By submitting your manuscript to this publication you accept that your manuscript may be screened for plagiarism against previously published works. Conflict of interest All authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work. Funding sources You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in: study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. Authorship Authors are required to meet the criteria for authorship as recommended by the International Committee of Medical Journal Editors (ICMJE). The specific contributions of each author must be described in an Author Contributions statement. Requests to add or remove an author, or to rearrange the author names, after acceptance of your paper must be sent to the Editorial Office and must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors, including those authors added or omitted, that they agree with the addition, removal or rearrangement. Any requests to add, delete, or rearrange author names after the article is published online will follow the same policies as noted above and result in a corrigendum. Work involving human or animal subjects or tissues The work described in your article must have been carried out in accordance the ARRIVE Guidelines for reporting in vivo animal experiments (http://www.nc3rs.org.uk/arrive-guidelines). Please include, in the Materials and Methods section, details of ethical guidelines (national or institutional) that were followed, and a description of any surgical procedures and peri-operative care. Research involving human subjects or human tissues should comply with The Code of Ethics of the World Medical Association (Declaration of Helsinki). Please include a statement within the Materials and Methods section, indicating that written informed consent has been obtained from each subject, and that the study methodologies have approval from the appropriate local ethics committee. Preprints and data availability Preprints FEBS Open Bio supports rapid and open scientific communication. Authors are free to upload their work to their personal website, their company’s/institution’s repository or archive, or a not-for-profit subject-based preprint server or repository ahead of or concurrently with submission to the journal. Posting a manuscript to a recognised preprint server does not constitute prior publication. Data accessibility FEBS Open Bio encourages authors to share the data behind the results in their paper. Submission of a research article is taken to imply that the authors are willing to make available to academic researchers November 2018 3 any cell lines, DNA clones, antibodies or similar materials that have been used in the experiments reported. Authors should comply with available field-specific standards for the preparation and recording of data. We recommend authors refer to the Minimum Information for Biological and Biomedical Investigations (MIBBI) Portal for prescriptive checklists for reporting biological and biomedical research where applicable: http://www.biosharing.org/standards/mibbi. Authors must deposit all ‘structured’ data sets (e.g. gene sequences, protein structures, microarray data, etc.) in the appropriate public databases and include the accession number in their paper. On the title page, please include a statement briefly describing the data sets and giving the accession numbers or DOIs. In addition, throughout the text, accession numbers for data stored in external databases will be hyperlinked to provide access to these data if provided in
Load more

Recommended publications
  • COVID-19 Evidence Update Date 7Th to 13Th September 2020
    UHB Library & Knowledge Services COVID-19 Evidence Update Date 7th to 13th September 2020 Evidence search Healthcare Databases Advanced Search (HDAS) 1. Medical mask versus cotton mask for preventing respiratory droplet transmission in micro environments. Author(s): Ho, Kin-Fai; Lin, Lian-Yu; Weng, Shao-Ping; Chuang, Kai-Jen Source: The Science of the total environment; Sep 2020; vol. 735 ; p. 139510 Publication Date: Sep 2020 Publication Type(s): Journal Article PubMedID: 32480154 DOI 10.1016/j.scitotenv.2020.139510 Database: MEDLINE 2. Update on neurological manifestations of COVID-19. Author(s): Yavarpour-Bali, Hanie; Ghasemi-Kasman, Maryam Source: Life sciences; Sep 2020; vol. 257 ; p. 118063 Publication Date: Sep 2020 Publication Type(s): Journal Article Review PubMedID: 32652139 Available at Life sciences from Unpaywall Database: MEDLINE 3. Forecasting the Future of Urology Practice: A Comprehensive Review of the Recommendations by International and European Associations on Priority Procedures During the COVID-19 Pandemic. Author(s): Amparore, Daniele; Campi, Riccardo; Checcucci, Enrico; Sessa, Francesco; Pecoraro, Angela; Minervini, Andrea; Fiori, Cristian; Ficarra, Vincenzo; Novara, Giacomo; Serni, Sergio; Porpiglia, Francesco Source: European urology focus; Sep 2020; vol. 6 (no. 5); p. 1032-1048 Publication Date: Sep 2020 Publication Type(s): Journal Article Review PubMedID: 32553544 Available at European urology focus from ClinicalKey You will need to register (free of charge) with Clinical Key the first time you use it. Available at European urology focus from Unpaywall Database: MEDLINE 4. Tongue Ulcers Associated with SARS-COV-2 Infection: A case-series. Author(s): Riad, Abanoub; Kassem, Islam; Hockova, Barbora; Badrah, Mai; Klugar, Miloslav Source: Oral diseases; Sep 2020 Publication Date: Sep 2020 Publication Type(s): Letter PubMedID: 32889763 Available at Oral diseases from Wiley Online Library Medicine and Nursing Collection 2020 Database: MEDLINE 5.
    [Show full text]
  • Issue 1/January, 2006
    Issue 1/January, 2006 by Camilla Krogh Lauritzen, FEBS Information Manager, Editor of FEBS News FEBS Secretariat, co/the Danish Cancer Society Strandboulevarden 49, DK-2100, Denmark E-mail: [email protected] FEBS website: www.FEBS.org Dear Colleagues, A new year has taken its start, and the 2006 FEBS Congress is only approx. six month away. This year, the Con- gress will take place in Istanbul, and again this year, the programme is packed with exiting topics and people — if you have not already done so, have a look at the Congress website, www.FEBS2006.org. Furthermore, please re- member that the FEBS Forum for Young Scientists will take place in connection with the congress (p. 3). 2006 marks "a changing of the guards" in terms of FEBS officers — on page 3 you will get a brief presentation of some known and some new faces in FEBS. Furthermore, you will be presented with the face of Luc Van Dyke (ELSF/ISE), as well as to his article, "Science policy — working together to shape our future". Luc is the debater in this issue of FEBS News, and will elaborate on the current status and importance of science policy science making within Europe (p.9). Finally, this issue will also bring you news from FEBS Letters and FEBS Journal, as well as new opportunities, such as up-coming FEBS courses (p. 8) and job opportunities (p. 10-13). I wish all of you a successful and happy 2006! Kind regards, Camilla About FEBS News: FEBS News is published every second Monday in every second month (starting January).
    [Show full text]
  • Quantitative Portrait of Open Access Mega-Journals
    Malaysian Journal of Library & Information Science, Vol. 24, no.2, August 2019: 115-131 Quantitative portrait of open access mega-journals Mohammadamin Erfanmanesh Department of Library and Information Science Faculty of Computer Science and Information Technology University of Malaya, Kuala Lumpur, MALAYSIA E-mail: [email protected]; [email protected] ABSTRACT Nowadays, Open Access Mega-Journals (OAMJs) represent a substantial part of the scholarly communication system. The current research is conducted with the aim of providing better insights into the increasingly important OAMJ phenomenon through investigation of eight reputable titles using established bibliometric methods. Results of the study showed that eight studied OAMJs were responsible for 1.87% of the total number of publication indexed in Web of Science during 2012-2016. Despite the decline in publication count of PLOS ONE over the past couple of years, it was the biggest journal in the world till 2017, when Scientific Reports overtook PLOS ONE as the most productive journal. Over 88% of the papers published in eight selected OAMJs were cited at-least once at the point in time of analysis. The highest proportions of cited and un-cited documents were seen in Scientific Reports and SpringerPlus, respectively. With regard to the three indicators, namely share of highly- cited papers, the category normalized citation impact as well as the JIF percentile, IEEE Access had by far the best performance among eight examined OAMJs. Results of the study revealed that Biochemistry & Molecular Biology, Multidisciplinary Sciences, Neurosciences, Oncology and Immunology were the most commonly assigned subject categories to OAMJs’ content.
    [Show full text]
  • A Presentation of the Self-Publishing Model (SPM) As the Advent of a New Era of Scientific Communication
    Self Publishing Model (SPM) A Presentation of the Self-Publishing Model (SPM) as the Advent of a New Era of Scientific Communication Author: Nour Ouda, Claus Jacob Endorsed by: Claus Jacob Edited by: Ahmad Yaman Abdin and Muhammad Jawad Nasim This manuscript is being published under the auspices of the Self Publishing Movement (SPM) to promote the free and unbiased exchange of scientific knowledge for all. The manuscript has not been refereed in order to protect the originality and to preserve the creativity of the author(s) and her/his/their ideas. Instead, it has been edited and endorsed by peers to ensure that format and content both adhere to acceptable international standards. Endorsements, criticism, comments and debate are always welcome. The intellectual property rights and copyright of this piece of original work reside with the author(s) and due credit should be given if this work is being cited. 0 Self Publishing Model (SPM) Abstract Traditional scientific dissemination via journals is problematic. It restricts the free exchange of knowledge due to financial restraints and, because of a subjective reviewing process, often impinges on authors’ originality. Eventually, important pieces of research are lost, whilst others are skewed in order to please anonymous referees. The Self-Publishing Movement (SPM) considers the free and open access to scientific knowledge as a right for all. Under the auspices of the SPM disseminating and acquiring knowledge is free of charge. The originality and creativity of authors’ work and ideas are preserved by avoiding the influence of referees. The standard linguistic and scientific quality of the work can be maintained by peer editors and endorsers before the dissemination.
    [Show full text]
  • Biocreative II.5 Workshop 2009 Special Session on Digital Annotations
    BioCreative II.5 Workshop 2009 Special Session on Digital Annotations The purified IRF-4 was also The main role of BRCA2 shown to be capable of binding appears to involve regulating the DNA in a PU.1-dependent manner function of RAD51 in the repair by by electrophoretic mobility shift homologous recombination . analysis. brca2 irf4 We found that cells ex- Moreover, expression of pressing Olig2, Nkx2.2, and NG2 Carma1 induces phosphorylation were enriched among virus- of Bcl10 and activation of the infected, GFP-positive (GFP+) transcription factor NF-kappaB. cells. carma1 BB I O olig2 The region of VHL medi- The Rab5 effector ating interaction with HIF-1 alpha Rabaptin-5 and its isoform C R E A T I V E overlapped with a putative Rabaptin-5delta differ in their macromolecular binding site within ability to interact with the rsmallab5 the crystal structure. GTPase Rab4. vhl Translocation RCC, bearing We show that ERBB2-dependenterbb2 atf1 TFE3 or TFEB gene fusions, are Both ATF-1 homodimers and tfe3 medulloblastoma cell invasion and ATF-1/CREB heterodimers bind to recently recognized entities for prometastatic gene expression can the CRE but not to the related which risk factors have not been be blocked using the ERBB tyrosine phorbol ester response element. identified. kinase inhibitor OSI-774. C r i t i c a l A s s e s s m e n t o f I n f o r m a t i o n E x t r a c t i o n i n B i o l o g y October 7th - 9th, 2009 www.BioCreative.org BioCreative II.5 Workshop 2009 special session | Digital Annotations Auditorium of the Spanish National
    [Show full text]
  • Download (142Kb)
    Volume 9 Supplement 1 July 2019 TALKS 13 Intracellular ion channels and transporters 15 RNA processing Table of Contents 16 Signal transduction PLENARY LECTURES 17 Mitochondria and signaling 18 DNA architecture Saturday 6 July 19 RNA transcription 3 Opening Plenary Lecture Monday 8 July Sunday 7 July 20 DNA editing and modification 3 IUBMB Lecture 22 RNA transport and translation 3 The FEBS Journal Richard Perham Prize Lecture 24 Single cell analysis and imaging 3 FEBS/EMBO Women in Science Award Lecture 25 Calcium and ROS signaling Monday 8 July 26 Sulfur metabolism and cellular regulation 27 Molecular neurobiology 4 FEBS Datta Lecture 29 RNA turnover 4 FEBS Sir Hans Krebs Lecture 30 Cytoskeleton and molecular mechanisms of motility Tuesday 9 July 31 Rare diseases 4 FEBS Theodor Bücher Lecture Tuesday 9 July 5 FEBS 2019 Plenary Lecture 32 Signaling in brain cancer Wednesday 10 July 34 Synthetic biopolymers for biomedicine 5 PABMB Lecture 35 Integrative approaches to structural and synthetic biology 5 EMBO Lecture 37 Induced pluripotent cells Thursday 11 July 39 Long noncoding RNA 40 Neurodegeneration 5 Closing Plenary Lecture 42 Cell therapy and regenerative medicine FEBS SPECIAL SESSIONS 44 Small noncoding RNA Sunday 7 July Wednesday 10 July 6 Gender issues in science 45 Proteins: structure, disorder and dynamics 47 Plant biotechnology Monday 8 July 48 Natural networks and systems 6 Education 1 – Creative teaching: effective learning in life sciences 50 RNA in pathogenesis and therapy education 51 Biochemistry, a success story Tuesday
    [Show full text]
  • Accounts of Chemical Research 8 (1975) - 21, 22 {1-11}, 23 - 30 (1997)
    A Accounts of Chemical Research 8 (1975) - 21, 22 {1-11}, 23 - 30 (1997) Acta Chemica Scandinavica 1 (1947) - 27 (1973) : Acta Chemica Scandinavica. 1974 - 1988 : Ser. Aと Ser. B . に分離 A 28 (1974) - A 42 (1988) : Ser. A : Physical and Inorganic Chemistry B 28 (1974) - B 42 (1988) : Ser. B : Organic Chemistry and Biochemistry 43 (1989) : 合併 Acta Chemica Scandinavica. 1 (1947) - 51 (1997) Acta Phytotaxonomica et Geobotanica →APG * Advances in Analytical Chemistry and Instrumentation 1 (1960) - 11 (1973) * Advances in Biological and Medical Physics 10 (1965) - 17 (1980) * Advances in Carbohydrate Chemistry → Advances in Carbohydrate Chemistry and Biochemistry * Advances in Carbohydrate Chemistry and Biochemistry 1 (1945) - 23 (1968) : Advances in Carbohydrate Chemistry 1 (1945) - 61 (2007) 62 (2008) + : 電子ジャーナル * Advances in Catalysis 1 (1948) - 21 (1970) : Advances in Catalysis and Related Subjects 1 (1948) - 41 (1996) * Advances in Catalysis and Related Subjects → Advances in Catalysis * Advances in Chemical Engineering 1 (1956) - 23 (1996) * Advances in Chemical Physics 1 (1958) - 58, 60 - 93, 95 - 96 (1996) * Advances in Clinical Chemistry 1 (1958) - 31 (1994) * Advances in Drug Research 1 (1964) - 12 (1977) * Advances in Electrochemistry and Electrochemical Engineering 1 1 (1961) - 13 (1984) * Advances in Enzyme Regulation 1 (1963) - 33 (1993) * Advances in Enzymology * Advances in Enzymology and Related Subjects * Advances in Enzymology and Related Subjects of Biochemistry → Advances in Enzymology and Related Areas of Molecular Biology
    [Show full text]
  • CRISPER-CAS System and Its Applications
    Bulletin of Environment, Pharmacology and Life Sciences Bull. Env. Pharmacol. Life Sci., Vol 9[9] August 2020 : 172-179 ©2020 Academy for Environment and Life Sciences, India Online ISSN 2277-1808 Journal’s URL:http://www.bepls.com CODEN: BEPLAD Global Impact Factor 0.876 Universal Impact Factor 0.9804 NAAS Rating 4.95 REVIEW ARTICLE OPEN ACCESS CRISPER-CAS System and Its Applications Devyani Jogran* , Jeetendra Singh Bohra and Pushpa Lohani Department of Molecular Biology and Genetic Engineering, College of Basic Science and Humanities G.B Pant University of Agriculture and Technology, Pantnagar, Uttarakhand *corresponding author email : [email protected] ABSTRACT The CRISPR-Cas focuses on adaptive immunity systems of many bacteria and nearly all archaea. Its discovery has proven it as a simple tool and its effectiveness for many aspects like Transcription Activator. It can be used to add desirable and remove undesirable alleles simultaneously in a single event. Presently CRISPR-Cas has emerged as a engineering tool to controlled genetic modification in many organisms like Staphylococcus aureus, Escherichia coli, Saccharomyces cerevisiae etc. CRISPR-Cas9 system has revolutionized the area of genome editing because of easy laboratory construction, targeting multiple genomic sites. The Cas9 enzyme has been used as a popular tool for directed gene editing used in medical research areas. It can be used as an effective gene therapy method in various genetic disorders where no curative treatment is available. Mainly it is used in microbial adaptive immune system, gene regulations, functional genomics, genome editing, Keywords: Genome editing, CRISPR-Cas Received 21.05.2020 Revised 15.06.2020 Accepted 23.07.2020 INTRODUCTION In 1970, recombinant DNA technology development marked the beginning of new era in biology.
    [Show full text]
  • 0 WILEY and MAYNOOTH UNIVERSITY WILEY READ AND
    WILEY and MAYNOOTH UNIVERSITY ________________________________________ WILEY READ AND PUBLISH AGREEMENT ________________________________________ 0 THIS AGREEMENT is made on the 15th day of March, 2021 BETWEEN: John Wiley & Sons, Inc., a New York corporation, 111 River Street, Hoboken, New Jersey 07030, and its affiliates Wiley Periodicals LLC, John Wiley & Sons, Ltd, John Wiley & Sons Australia, Ltd, Wiley-VCH GmbH, John Wiley & Sons A/S, collectively “Wiley” or “Publisher” AND National University of Ireland Maynooth, Maynooth University, whose principal address is at Maynooth, Co Kildare, Ireland (“Maynooth University”), acting on its own behalf and as non-exclusive agent on behalf of the other Members of the Consortium. RECITALS WHEREAS Maynooth University has been appointed by Members of the Consortium, as their non-exclusive agent, to enter into agreements on the Members’ behalf for accessing electronic educational and research resources; AND WHEREAS the Publisher provides Wiley Online Library which is an electronic collection of online journals, books, and research resources, covering life, health, social, and physical sciences, and the Publishing Privilege that gives authors the option to publish articles on an open access basis in select Wiley journals.; AND WHEREAS Maynooth University wishes to enter into this Agreement in order for Members of the Consortium to be authorised to access and use the Licensed Material; AND WHEREAS the Consortium and the Publisher share the goal to transition to an open access model and the transition to full open access will include continued access to the Publisher’s journal content, AND WHEREAS the parties are desirous to contract on the basis of the terms and conditions of this Agreement.
    [Show full text]
  • Issue 3 (November) 2014
    ISSUE 3 (NOVEMBER) 2014 40th FEBS Congress FEBS programmes: FEBS–EMBO 2014 FEBS publications FEBS community updates conference round-up news Page 4 Page 8 Page 12 Page 26 Page 35 CONTENTS Contents: Key upcoming dates for Preface 3 FEBS activities FEBS Programmes: updates 40th FEBS Congress 40th FEBS Congress, Berlin, 2015 4 4–9 July 2015 FEBS Advanced Courses 8 Abstract submission deadline: 2 March 2015 FEBS Education Activities 11 Bursary application deadline: 2 March 2015 Early-bird registration deadline: 12 March 2015 FEBS–EMBO 2014 Conference Round-up www.febs2015.org The FEBS–EMBO 2014 Conference 12 FEBS Awards 14 FEBS Young Scientists’ Forum FEBS Workshops and Events 17 2–4 July 2014 FEBS Young Scientists’ Forum 2014 22 Application deadline: 31 January 2015 bit.ly/YSF2015 FEBS Fellows Meeting 2014 24 FEBS 50th Anniversary Dinner 25 FEBS Advanced Courses Applications for 2016 course funding: 1 March 2015 FEBS Publications Applications to participate in 2015 courses: see FEBS Publications at FEBS–EMBO 2014 26 individual course deadlines Digital Developments 28 www.febs.org/our-activities/advanced- Journal Highlights and Special Issues 33 courses/2015-advanced-courses FEBS Community News FEBS – Biochemical Society FEBS-sponsored Lectures 35 Education Workshop Obituary 38 FEBS Education Workshop bursaries deadline: FEBS Council: Elections 39 1 December 2014 Abstract submission deadline: 26 January 2015 Scientific Events Calendar 40 www.febs.org/our-activities/education Cover: Berlin, at the heart of the FEBS area, is the location for the 2015 FEBS Congress, hosted this time by the German Society for Biochemistry and Molecular Biology. Registration and abstract submission for the Congress have opened, and the event is introduced on pages 4–7 of this issue of FEBS News.
    [Show full text]
  • Issue Information
    Volume 6 Number 2 February 2016 ISSN 2211-5463 febsopenbio.org FFEB4_v6_i2_IssueEB4_v6_i2_Issue info.inddinfo.indd 1 116-02-20166-02-2016 16:51:2516:51:25 EDITORIAL BOARD EDITORIAL OFFICE Senior Editors Laszlo Nagy Mary Purton, Executive Editor, FEBS Open Bio SBP Medical Discovery Institute, USA 98 Regent Street, Cambridge CB2 1DPUK Julio Celis and University of Debrecen, Hungary Institute of Cancer Biology, [email protected] Copenhagen, Denmark Zhen-Ming Pei Duke University, Durham, North Carolina, PRODUCTION OFFICE Stuart Ferguson USA University of Oxford, UK Marion Laws Jan S. Potempa Seamus Martin John Wiley & Sons Ltd, 9600 Garsington Road, Jagiellonian University Kraków, Poland Trinity College, Dublin, Ireland Oxford OX4 2DQ, UK Thomas Preiss [email protected] Felix Wieland Australian National University, Canberra, Ruprecht-Karls-Universität Heidelberg, Volume 6 Number 2 February 2016 Australia ISSN 1742-464X Germany Kristine Kleivi Sahlberg Associate Editors Oslo University Hospital, Norway Alberto Alape Giron Cristiano Simone Universidad de Costa Rica, San José, Università degli Studi di Bari Costa Rica Aldo Moro, Bari, Italy febsopenbio.org Edurne Berra Ramírez FEB4_v6_i2_oc.indd 1 16-02-2016 16:42:00 Sandro Sonnino CIC Biogune, DERIO, Spain Università degli Studi di Milano, Cover Illustration Antonio Castrillo Viguera Segrate, Italy In vivo fluorescence correlation spectroscopy analyses of FMBP-1, a silkworm transcription factor. From M. Tsutsumi et al. (pp. 106ă125). Instituto Investigaciones Biomedicas Michael Sussman Alberto Sols, Madrid, Spain University of Wisconsin at Madison, USA Pierre Cosson Tibor Vellai Université de Genève, Centre Medical Eötvös Lorand University, Budapest, Online ISSN: 2211-5463 Universitaire, Geneve 4-CH, Hungary This journal is Open Access; all articles will be immediately and Switzerland permanently free for everyone to read and download.
    [Show full text]
  • (September) 2013
    ISSUE 3 (SEPTEMBER) 2013 38th FEBS Congress FEBS programmes: FEBS community FEBS publications Scientific events round-up updates news calendar Page 3 Page 16 Page 20 Page 22 Page 27 CONTENTS Key upcoming dates for FEBS activities Contents: FEBS Congress Round-up FEBS–EMBO 2014 Conference 30 August – 4 September 2014 The 38th FEBS Congress 3 Abstract submission from December 2013 FEBS Medals and Awards 6 Registration from January 2014 FEBS Young Scientists’ Forum 8 www.febs-embo2014.org FEBS Congress Workshops 9 FEBS Congress Science and Society Lecture 12 FEBS Young Scientists’ Forum 27–30 August 2014 FEBS Programmes: updates Applications: 8 December 2013 – 31 March 2014 FEBS Advanced Courses 2014 16 www.febs-embo2014.org FEBS Education Workshops 17 FEBS–EMBO 2014 Conference, and FEBS YSF 18 FEBS Advanced Courses Applications for 2015 course funding: 1 March 2014 FEBS Community News Applications to participate in 2014 courses: see Spanish (SEBBM) Society 20 individual course deadlines Polish Biochemical Society 21 www.febs.org/index.php?id=86 FEBS Publications FEBS Fellowships FEBS Journal 22 Application deadlines: FEBS Letters 24 Long-Term and Return-to-Europe Fellowships: 1 October 2013, then 1 October 2014 Molecular Oncology 25 Summer Fellowships: 1 April 2014 FEBS Open Bio 26 Follow-up Research Fund (for FEBS Fellows): 1 April 2014 Applications for other Fellowships can be 27 Scientific Events Calendar submitted throughout the year Career Opportunities 28 www.febs.org/index.php?id=81 Cover: While this issue of FEBS News reports on the 2013 FEBS Congress in St Petersburg (pages 3–5), plans are already under way for next year’s big event – a joint anniversary conference with EMBO (the FEBS–EMBO 2014 Conference), hosted by the French Society for Biochemistry and Molecular Biology (see pages 18–19).
    [Show full text]